Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In a double-blind, placebo-controlled, phase 2b trial, patients with diabetes were administered all doses of tirzepatide, dulaglutide, or placebo
Ferrari G, Cook BD, Terushkin V, Pintucci G, Mignatti P
Specific IHD-associated biomarkers, which may have biological significance in distinguishing between control and IHD conditions, were identified and further confirmed through ROC curve analysis
Nature , 432(7016), 640645
US$ 26.32
US$ 20.73
US$ 23.02
US$ 29.55
US$ 21.03
US$ 22.79
